| Income Statement for Labopharm Inc. (DDSS) | | | | | | | Income | in Thousands of Dollars | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | | | Operating Revenue | 19,129 | 13,626 | 3,224 | 1,162 | | Adjustments to Revenue | - | - | - | - | | Cost of Revenue | (7,009) | (3,937) | (652) | - | | Gross Operating Profit | 12,120 | 9,689 | 2,572 | 1,162 | | | Selling/General/Admin Expense | (20,475) | (14,605) | (10,480) | (8,213) | | Research & Development | (23,746) | (13,424) | (16,973) | (12,679) | | EBITDA | (32,101) | (18,340) | (24,881) | (19,730) | | Depreciation & Amortization | (2,244) | (1,801) | (1,431) | (1,385) | | EBIT | (34,345) | (20,141) | (26,312) | (21,115) | | Interest Income | 3,502 | 2,901 | 479 | - | | Other Income, Net | (37) | 866 | (134) | 496 | | Total Income Avail For Interest Expense | (32,407) | (16,374) | (25,967) | (21,877) | | Interest Expense | (1,901) | (2,278) | (1,666) | (739) | | Pre-Tax Income | (34,308) | (18,652) | (27,633) | (22,616) | | Income Taxes | (2,518) | (1,834) | (1,031) | (34) | | Minority Interest | - | - | - | - | | Net Income from Continuing Operations | (36,827) | (20,486) | (28,664) | (22,651) | | Net Income from Discontinued Operations | - | - | - | - | | Net Income from Total Operations | (36,827) | (20,486) | (28,664) | (22,651) | | | Normalized Income | (35,300) | (20,486) | (28,664) | (21,393) | | Extraordinary Income | - | - | - | - | | Special Income/Charges | (1,527) | - | - | (1,258) | | Income from Cum. Effect of Acct Change | - | - | - | - | | Income from Tax Loss Carryforward | - | - | - | - | | Other Gains | - | - | - | - | | Total Net Income | (36,827) | (20,486) | (28,664) | (22,651) | | | Results | in Dollars (Preferred Dividends in Thousands) | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | | | Dividends Paid Per Share | 0.00 | 0.00 | 0.00 | 0.00 | | Preferred Dividends | - | - | - | - | | | Basic EPS from Continuing Operations | -0.64 | -0.39 | -0.67 | -0.57 | | Basic EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | | Basic EPS from Total Operations | -0.64 | -0.39 | -0.67 | -0.57 | | | Diluted EPS from Continuing Operations | -0.64 | -0.39 | -0.67 | -0.57 | | Diluted EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | | Diluted EPS from Total Operations | -0.64 | -0.39 | -0.67 | -0.57 | | | |
